"There is really no
incentive for the PBMs acting on behalf of their clients, the plans, to do
anything in terms of a utilization management standpoint or negotiation
standpoint outside of just bringing the generics on formulary."
— Michael Schneider, a principal at Avalere Health, spoke with
AIS's RADAR on Drug Benefits
about the protections placed on HIV drugs, and why utilization management
strategies are rare in the class.
No comments:
Post a Comment